Rchr
J-GLOBAL ID:201801019352960234   Update date: Sep. 28, 2024

MIYAZAKI Mitsue

MIYAZAKI Mitsue
Research field  (1): Animals: biochemistry, physiology, behavioral science
Research theme for competitive and other funds  (1):
  • 2022 - 2025 脂肪細胞分化抑制因子EID1はヒト肝細胞への脂肪の蓄積を抑制するか
Papers (22):
  • Takeshi Akiyoshi, Rina Naitou, Ayuko Imaoka, Mitsue Miyazaki, F Peter Guengerich, Katsunori Nakamura, Koujiro Yamamoto, Hisakazu Ohtani. Time-dependent inhibition of CYP3A4-mediated midazolam metabolism by macrolide antibiotics in CYP3A4 genetic variants: Comparison with testosterone metabolism. International journal of clinical pharmacology and therapeutics. 2021. 59. 12. 745-752
  • Yuki Yamaguchi, Takeshi Akiyoshi, Go Kawamura, Ayuko Imaoka, Mitsue Miyazaki, F Peter Guengerich, Katsunori Nakamura, Koujirou Yamamoto, Hisakazu Ohtani. Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants. Drug metabolism and pharmacokinetics. 2021. 38. 100384-100384
  • Tomohiko Sato, Diana Vargas, Kakushin Miyazaki, Kaoru Uchida, Winda Ariyani, Mitsue Miyazaki, Junichi Okada, Fernando Lizcano, Noriyuki Koibuchi, Noriaki Shimokawa. EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3-L1 preadipocytes. Journal of cellular physiology. 2020. 235. 10. 6725-6735
  • Ayumu Nagamine, Takuya Araki, Daisuke Nagano, Mitsue Miyazaki, Koujirou Yamamoto. L-Lactate dehydrogenase B may be a predictive marker for sensitivity to anti-EGFR monoclonal antibodies in colorectal cancer cell lines. Oncology letters. 2019. 17. 5. 4710-4716
  • 川村 豪, 今岡 鮎子, 秋好 健志, 日比野 英幸, 荒木 拓也, 宮崎 光江, Guengerich F.P., 中村 克徳, 中村 智徳, 山本 康次郎, et al. CYP3A4 genetic variantsに対する各種アゾール系抗真菌薬の阻害特性の比較. 日本薬学会年会要旨集. 2017. 137年会. 4. 191-191
more...
MISC (2):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page